NCT07342517 2026-03-17
RESCUE
Relmada Therapeutics, Inc.
Phase 3 Withdrawn
Clinical Trials
16 trialsNCT06240390 2026-03-09
Effectiveness of Percutaneous Neuromodulation vs Pharmacological Treatment in Cancer Patients With Anterior Knee Pain
Universidad Europea de Canarias
Phase NA Withdrawn
NCT06922825 2026-01-21
Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT03135743 2026-01-16
LYMPHOSYNCHRO
Centre Hospitalier Universitaire, Amiens
Withdrawn
NCT07293520 2025-12-26
Improving Consent Experiences in Clinical Trials
Washington University School of Medicine
Phase NA Withdrawn
NCT04020029 2025-12-19
Leveraging Mindsets to Improve Health and Wellbeing in Patients With Cancer
Stanford University
Phase NA Withdrawn
NCT06690281 2025-09-11
A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT05052632 2025-08-13
Evaluating a New Gonadotoxic Risk Stratification System
University of Colorado, Denver
Withdrawn
NCT05000905 2025-08-06
Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention Training
University of California, San Francisco
Phase NA Withdrawn
NCT05917990 2025-07-28
Dyadic Text-Messaging Micro-Intervention
Duke University
Phase NA Withdrawn
NCT06161558 2025-07-16
Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Withdrawn
NCT05257707 2025-07-09
MOCA
Centre Hospitalier Universitaire de Besancon
Phase NA Withdrawn
NCT02077621 2025-06-04
Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer
PhytoHealth Corporation
Phase 2 Withdrawn
NCT06390657 2025-05-11
S-C-PATHY
EBG MedAustron GmbH
Withdrawn
NCT05900908 2025-04-10
PATHWAyS
GT Medical Technologies, Inc.
Phase 4 Withdrawn
NCT06351306 2025-03-24
DEC-C and Thioguanine for R/R AML
Columbia University
Phase 2 Withdrawn